Results 131 to 140 of about 1,975 (157)
Some of the next articles are maybe not open access.
Epigenetic modification facilitates proline synthase PYCR1 aberrant expression in gastric cancer
Biochimica Et Biophysica Acta - Gene Regulatory Mechanisms, 2022Pyrroline-5-carboxylate reductase 1 (PYCR1) upregulation contributes to the progression of gastric cancer (GC) and indicates poor survival. However, PYCR1 expression profile in GC subtypes and the mechanism behind its upregulation are not well-studied.PYCR1 expression profiles in GC subtypes and different stages of gastric carcinogenesis were assessed ...
Liya Zhou, Shiyu Xiao, Yin Zhihao
exaly +3 more sources
MiR-328–3p inhibits lung adenocarcinoma-genesis by downregulation PYCR1
Biochemical and Biophysical Research Communications, 2021A vast majority of patients with NSCLC (non-small cell lung cancer) have lung adenocarcinoma (LA), and the survival rate of LA varies from 5% to 75% depending on the severity of this adenocarcinoma. PYCR1 (abnormal pyrroline-5-carboxylate reductase 1) gene and miR-328-3p have been found to be associated with cancer development.
Jiancong Lu
exaly +3 more sources
PYCR1 expresses in cancer-associated fibroblasts and accelerates the progression of C6 glioblastoma.
Cancer-associated fibroblasts (CAFs) play important roles in tumor microenvironments. Pyrroline-5-carboxylate reductase 1 (PYCR1) is a potential cancer therapy target. This study aimed to explore the expression of PYCR1 in glioma-associated CAFs and analyze the effects of PYCR1 expression in CAFs on the proliferation of C6 glioma.A rat glioma model was
Mingkun Zhang +3 more
semanticscholar +3 more sources
Journal of Gene Medicine
The expression and functional role of pyrroline‐5‐carboxylate reductase 1 (PYCR1) in esophageal squamous cell carcinoma (ESCC) remain poorly understood. This study aimed to elucidate the role and underlying mechanisms of PYCR1 in ESCC.
Yu-Qi Meng +6 more
semanticscholar +1 more source
The expression and functional role of pyrroline‐5‐carboxylate reductase 1 (PYCR1) in esophageal squamous cell carcinoma (ESCC) remain poorly understood. This study aimed to elucidate the role and underlying mechanisms of PYCR1 in ESCC.
Yu-Qi Meng +6 more
semanticscholar +1 more source
DJ-1 cooperates with PYCR1 in cell protection against oxidative stress
Biochemical and Biophysical Research Communications, 2013DJ-1, a product of the DJ-1/PARK7 gene, has been suggested to play various functions involved in transcriptional regulation, protease activity, anti-oxidative stress activity, and regulation of mitochondrial complex I. Such a variety of functions of DJ-1 are supposed to be realized through interactions with different partner proteins.
Tatsuki, Yasuda +7 more
openaire +2 more sources
The role of Pycr1 in the pathomechanism of autosomal recessive cutis laxa
2014Cutis laxa is an umbrella term for several disorders having in common lax and wrinkled skin most likely due to rarefaction of elastic fibers in the connective tissues. Autosomal recessive cutis laxa (ARCL) with progeroid features caused by mutations in PYCR1 is mainly characterized by intrauterine growth retardation, connective tissue weakness, reduced ...
openaire +3 more sources
Cancer Research
Pyrroline-5-carboxylate reductase 1 (PYCR1), a member of the PYCR enzyme family, plays a pivotal role in the proline biosynthesis pathway. Enzymes involved in proline metabolism have been increasingly recognized as key regulators of cancer cell ...
O. Tarkhanova +6 more
semanticscholar +1 more source
Pyrroline-5-carboxylate reductase 1 (PYCR1), a member of the PYCR enzyme family, plays a pivotal role in the proline biosynthesis pathway. Enzymes involved in proline metabolism have been increasingly recognized as key regulators of cancer cell ...
O. Tarkhanova +6 more
semanticscholar +1 more source
PYCR1 inhibition in multiple myeloma-associated stromal cells limits tumor growth.
2023Introduction Multiple myeloma (MM) is a hematological cancer, characterized by the accumulation of monoclonal plasma cells in the bone marrow. It remains an incurable cancer due to drug resistance, wherein the bone marrow microenvironment plays a crucial role. We have previously shown that glutamine-to-proline conversion is upregulated in MM cells upon
Oudaert, Inge, Menu, Eline
openaire +1 more source

